Research Nester published a report titled “Lipase Reagent Market: Global Demand Analysis & Opportunity Outlook 2035” which delivers a detailed overview of the global lipase reagent market in terms of market segmentation by type, application, and by region.
Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.
The global lipase reagent market is estimated to garner the most significant revenue by growing at ~7% CAGR over the forecast period, i.e., 2023 – 2035. The market is segmented by application into hospitals, clinics & others. Out of these, the hospital segment is anticipated to hold the largest share in the global lipase reagent market on account of expanding the healthcare sector and advancements in technology within the medical sector for diagnostics and therapeutics.
For More Information: https://www.researchnester.com/reports/lipase-reagent-market/4247
The global lipase reagent market is anticipated to grow on the back of high demand for lipase testing reagent for gastric issues. An increasing number of patients suffering from different diseases that require lipase analysis is estimated to attribute to the growth of the market during the forecast period. Additionally, the rise of indigestion, acute and chronic pancreatic disorders, gastroesophageal reflux disease (GERD), and other intestinal disorders increase widespread demand for lipase testing reagents during the forecast period. The prevalence of acute pancreatitis in 2010, increased from 28 to 36 per every 100,000 population. The growth of the market is contributed to the increase in diseases like vitamin deficiency, dehydration, malnutrition, high gastric acids, and persistent diarrhea. Along with this, the high demand for lipase testing reagents and the growth of the lipase reagent market is boosting the market share by an increase in the number of children with cystic fibrosis (CF) or Schwachman-Diamond Syndrome (SDS) diagnosis. As per the data from the World Gastroenterology Organization, among 100%, about 49% of females and 36.6% of males are suffering from the most common disorders like constipation, diarrhea, IBS, proctalgia fungax, and dyspepsia at rates of 11.7%, 4.7%, 4.1%, 5.9%, and 7.2% respectively.
Geographically, the global lipase reagent market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in North America region is estimated to witness noteworthy growth over the forecast period on the back of increasing concern among people about complications related to the gastrointestinal tract.
The research is global in nature and covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.
High Demand for Lipase testing Reagent in Concern of Gastric Issues to Increase Market Growth Opportunities
As per WHO, 1.7 billion childhood diarrheal disease cases were stated globally every year across the world.
The rising concern for the diagnosis of gastric issues is estimated to boost the market growth during the coming years. The lipase reagent market growth can be also attributed to the rise of pancreatic disorders and other gastric issues. In 2010, the prevalence of acute pancreatitis cases increased from 28 per 100,000 population in 1999 to 36 per every 100,000 population.
However, the lack of a proper healthcare system in low-income regions and less awareness of the diagnosis and gastric issues are expected to operate as key restraints to the growth of the global lipase reagent market over the forecast period.
This report also provides the existing competitive scenario of some of the key players of the global lipase reagent market which includes company profiling of DIALAB, DiaSys Diagnostic Systems GmbH, Sunson Industry Group Co.,Ltd, Randox Laboratories Ltd., Abbott Laboratories, Beckman Coulter, Inc., Compare Networks, Inc., Vitro Scient Co., Merck Group, Sisco Research Laboratories Pvt. Ltd., and Biosystems S.A. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials, and recent news and developments. On the whole, the report depicts detailed overview of the global lipase reagent market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching for possibilities and other stakeholders to align their market-centric strategies according to the ongoing and expected trends in the future.
Request Report Sample@ https://www.researchnester.com/sample-request-4247
About us
Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.
Contact for more Info:
AJ Daniel
Email: [email protected]
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919